New platform module automates previous manual vaccine design processes, improving quality and dramatically reducing time and resource requirementsAI-Immunology™, already superior...
Launch Follows IM8’s Record Growth to $6.6 Million Monthly Revenue in September IM8 Accelerates Toward $100 Million ARR Milestone with...
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with...
The DEA Regulatory Revolving Door Spins AgainAfter years of blocking FDA approved cannabis research for Huntington's and Multiple Sclerosis, former...
Constitutional Earthquake: The End of the DEA's In-House CourtDOJ's reversal on administrative law judge protections vindicates MMJ BioPharma's constitutional challenge...
Provides comprehensive, AI-powered solutions to help states deliver sustainable, high-quality healthcare in rural communities Offers recommendations to states seeking to...
CONSHOHOCKEN, Pa., Oct. 7, 2025 /PRNewswire/ -- Suvoda (recently merged with Greenphire), a global clinical trial technology company specializing in software...
Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies MORRISVILLE, N.C., Oct. 7, 2025...
RealTime eClinical Solutions co-authors industry-first guide for sponsor-site collaboration on technology choice. SAN ANTONIO, Oct. 7, 2025 /PRNewswire/ -- When...
FAYETTEVILLE, Ark., Oct. 7, 2025 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with dozens of leading...
In this free webinar, learn how biomarkers and digital tools are improving clinical trials in neurodegenerative diseases. Attendees will understand the...
Calgary, Alberta--(Newsfile Corp. - October 7, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
ATLANTA, GEORGIA / ACCESS Newswire / October 7, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSIONThe Summit theme "unlocking the $1 Trillion Wealth transfer...
Parexel’s Site Alliance Program strengthens global partnerships with clinical research sites and reinforces leadership in site engagement excellenceRALEIGH, N.C., Oct....
-- Integrating a computational workflow that leverages multi-omics data with a proprietary, humanized in vivo screening platform, T-knife identified highly...
Derisq delivers actionable insights about drug safety, efficacy and off-target risks prior to committing development capitalBOSTON, Oct. 07, 2025 (GLOBE...
Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184SOUTH...
SAN CARLOS, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity...
NORCROSS, Ga., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3...